Drug profile

The FDA adverse-event record for Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids

61 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids. See the species affected, top reactions, and outcomes below.

61
adverse-event reports
3.3%
death-coded share
Dog
most-reported species
18
Emesis - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
61
Total Reports
2
Deaths Reported
3.3%
Death Rate

Active Ingredients

Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids

Administration Routes

OralUnknown

Species Affected

Dog 61

Most Affected Breeds

Retriever - Labrador 6
Terrier (unspecified) 5
Shepherd Dog - German 4
Retriever - Golden 3
Pug 3
Beagle 3
Collie - Border 3
Retriever (unspecified) 2
Boxer (German Boxer) 2
Shepherd Dog - Australian 2

Most Reported Reactions

Emesis 18
Vomiting 11
Lack of efficacy - NOS 8
Lethargy (see also Central nervous system depression in 'Neurological') 7
Diarrhoea 7
Decreased appetite 5
Elevated liver enzymes 5
INEFFECTIVE, ANTIINFLAMMATORY 5
Other abnormal test result NOS 4
Lymphopenia 4
Behavioural disorder NOS 3
Lack of efficacy (endoparasite) - hookworm 3

Outcome Breakdown

Recovered/Normal
27 (44.3%)
Outcome Unknown
19 (31.1%)
Ongoing
9 (14.8%)
Recovered with Sequela
4 (6.6%)
Died
1 (1.6%)
Euthanized
1 (1.6%)

Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids Adverse Event Insights

61 reports name Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids; 2 recorded a death outcome (3.3% of reported events, not a population-level mortality rate). Active ingredient: Phycocyanin + Glucosamine + Methylsulfonylmethane + Minerals + Essential Fatty Acids. Administration routes: Oral, Unknown.

By species: Dog (61 reports). By breed: Retriever - Labrador (6), Terrier (unspecified) (5), Shepherd Dog - German (4).

Leading clinical signs: Emesis (18), Vomiting (11), Lack of efficacy - NOS (8), Lethargy (see also Central nervous system depression in 'Neurological') (7). Outcome, 61 coded reports: Recovered/Normal leads at 44.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.